Rockwood Kenneth, Song Xiaowei, MacKnight Chris, Bergman Howard, Hogan David B, McDowell Ian, Mitnitski Arnold
Division of Geriatric Medicine, Dalhousie University, Halifax, NS.
CMAJ. 2005 Aug 30;173(5):489-95. doi: 10.1503/cmaj.050051.
There is no single generally accepted clinical definition of frailty. Previously developed tools to assess frailty that have been shown to be predictive of death or need for entry into an institutional facility have not gained acceptance among practising clinicians. We aimed to develop a tool that would be both predictive and easy to use.
We developed the 7-point Clinical Frailty Scale and applied it and other established tools that measure frailty to 2305 elderly patients who participated in the second stage of the Canadian Study of Health and Aging (CSHA). We followed this cohort prospectively; after 5 years, we determined the ability of the Clinical Frailty Scale to predict death or need for institutional care, and correlated the results with those obtained from other established tools.
The CSHA Clinical Frailty Scale was highly correlated (r = 0.80) with the Frailty Index. Each 1-category increment of our scale significantly increased the medium-term risks of death (21.2% within about 70 mo, 95% confidence interval [CI] 12.5%-30.6%) and entry into an institution (23.9%, 95% CI 8.8%-41.2%) in multivariable models that adjusted for age, sex and education. Analyses of receiver operating characteristic curves showed that our Clinical Frailty Scale performed better than measures of cognition, function or comorbidity in assessing risk for death (area under the curve 0.77 for 18-month and 0.70 for 70-month mortality).
Frailty is a valid and clinically important construct that is recognizable by physicians. Clinical judgments about frailty can yield useful predictive information.
目前尚无一个被普遍接受的衰弱临床定义。先前开发的用于评估衰弱的工具虽已证明可预测死亡或入住机构设施的需求,但尚未得到临床医生的认可。我们旨在开发一种兼具预测性且易于使用的工具。
我们制定了7分临床衰弱量表,并将其与其他已确立的测量衰弱的工具应用于2305名参与加拿大健康与老龄化研究(CSHA)第二阶段的老年患者。我们对该队列进行了前瞻性随访;5年后,我们确定了临床衰弱量表预测死亡或机构护理需求的能力,并将结果与其他已确立工具所得结果进行关联。
CSHA临床衰弱量表与衰弱指数高度相关(r = 0.80)。在调整了年龄、性别和教育程度的多变量模型中,我们量表每增加1个类别,显著增加了中期死亡风险(约70个月内为21.2%,95%置信区间[CI] 12.5% - 30.6%)和入住机构的风险(23.9%,95% CI 8.8% - 41.2%)。受试者工作特征曲线分析表明,我们的临床衰弱量表在评估死亡风险方面比认知、功能或合并症测量表现更好(18个月死亡率的曲线下面积为0.77,70个月死亡率为0.70)。
衰弱是一种有效的且具有临床重要性的概念,医生能够识别。关于衰弱的临床判断可产生有用的预测信息。